Managing Antiplatelet Therapy in Stable Coronary Artery Disease
Mackram F. Eleid, M.D.
How long should I continue dual anti-platelet therapy after coronary intervention?
Is the duration of anti-platelet therapy the same for patients who receive stents in the setting of acute MI verses those who have not had myocardial injury?
When is it ok to interrupt dual anti-platelet therapy for non-cardiac procedures; what is the best strategy?
How do I decide when to use an agent other than clopidogrel with aspirin; what is the absolute net benefit of these other agents?
How should I manage anti-platelet therapy in patients who need anticoagulation in addition to antiplatelet therapy?